Results 61 to 70 of about 3,117,179 (310)
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
Mature B-cell neoplasms constitute a biologically and clinically heterogeneous group of hematologic malignancies, defined by the clonal proliferation and accumulation of monotypic mature B lymphocytes, which may involve the peripheral blood, bone marrow (
Vincenzo Ingangi +16 more
doaj +1 more source
P(論文)近年,癌治療技術の進歩に伴い口腔癌の治療成績も向上してきているが,未だ癌細胞の有する造腫瘍性,浸潤・転移能などの悪性形質に起因する再発,転移により制御不能となる場合も少なくないのが現状である。癌細胞の悪性形質は,必ずしも発癌当初より備わっているわけではなく,主に発癌後の増殖過程において周囲の微小環境との関わり,特に炎症局所において高頻度,長時間持続放出される活性酸素の影響などによって,遺伝子変化が蓄積し獲得されているらしいことが種々の臓器の癌で証明されて来ている。また ...
中井, 一元, 25316
core
Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari +5 more
wiley +1 more source
Increasing evidence indicates that the ability of cancer cells to convey biological information to recipient cells within the tumor microenvironment (TME) is crucial for tumor progression.
Xiaojie Bian +6 more
doaj +1 more source
CXCL8 in Tumor Biology and Its Implications for Clinical Translation
The chemokine CXCL8 has been found to play an important role in tumor progression in recent years. CXCL8 activates multiple intracellular signaling pathways by binding to its receptors (CXCR1/2), and plays dual pro-tumorigenic roles in the tumor ...
Xingyu Xiong +8 more
doaj +1 more source
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman +9 more
wiley +1 more source
Glioblastoma (GBM) is the most aggressive and common primary brain tumor in adults and remains associated with a dismal prognosis despite standard-of-care treatment.
Mohamed Abd Naceur Ammar +5 more
doaj +1 more source
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Chondrosarcoma (ChS), a malignant cartilage-producing tumor, is the second most frequently diagnosed osseous sarcoma after osteosarcoma. It represents a very heterogeneous group of malignant chemo- and radiation-resistant neoplasms, accounting for ...
Vincenzo Ingangi +10 more
doaj +1 more source
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth [PDF]
Background: Anti-cancer chemotherapy can be simultaneously lymphodepleting and immunostimulatory. Pre-clinical models clearly demonstrate that chemotherapy can synergize with immunotherapy, raising the question how the immune system can be mobilized to ...
Amy Prosser +51 more
core +2 more sources

